Discovery Laboratories Inc.
Edit Page
Report
Scan day: 05 February 2014 UTC
21
Virus safety - good
Description: Develops and commercializes surfactant pulmonary formulations for neonatal care. Information on company, technology, investors and careers. (Nasdaq: DSCO)
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Conference Call Wednesday, November 13, 2013 at 10:00 a.m. ET (lucinactant) Intratracheal Suspension is approved by the U.S. Food and Drug Administration (FDA) for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for developing RDS.
Size: 403 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Discovery Labs - Index |
| Keywords: | |
| Description: | |
| IP-address: | 64.71.33.111 |
WHOIS Info
| NS | Name Server: DBRU.BR.NS.ELS-GMS.ATT.NET Name Server: DMTU.MT.NS.ELS-GMS.ATT.NET |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 20-mar-1997 Expiration Date: 21-mar-2021 |